13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001846368
Total reported value
$7.2B
$7.2B
128 檔
66.9%
During the Q3 2025 filing period, Simplify Asset Management Inc. (CIK: 0001846368) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $7.2B across 128 reported positions.
Simplify Asset Management Inc. executed strategic sector rebalancing during Q3 2025, establishing 11 new positions while fully exiting 7 holdings and trimming 17 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SBIL | Simplify Govt Mny Mrkt ETF | ETF-Other | 61.13% | -2.27% | — | |
| 2 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 12.25% | -0.08% | -10.74% | |
| 3 | GLD | Spdr Gold Shares | ETF-Commodities | 8.31% | +0.57% | NEW | |
| 4 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 5.18% | +0.69% | -9.86% | |
| 5 | QIS | Simplify Multi-qis Alt ETF | ETF-Other | 1.63% | -0.17% | +17.82% | |
| 6 | IBIT | Ishares Bitcoin Trust ETF | ETF-Crypto | 1.56% | +0.03% | +152.16% | |
| 7 | SPUC | Simplify US Eqty Plus Up | ETF-Other | 1.51% | +0.01% | -14.57% | |
| 8 | AGGH | Simplify Aggregate Bond ETF | ETF-Other | 1.42% | -0.07% | -28.40% | |
| 9 | NMB | Simplify National Muni Bnd | ETF-Other | 0.72% | -0.04% | -42.77% | |
| 10 | NXTI | Simplify Next Intg C Idx ETF | ETF-Other | 0.49% | +0.03% | +3586.96% | |
| 11 | XV | Simplify Target 15 Distr ETF | ETF-Other | 0.48% | -0.01% | -2.56% | |
| 12 | PAGP | Plains Gp Holdings Lp-cl A | Stock-Energy | 0.43% | -0.04% | — | |
| 13 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.20% | — | +0.91% | |
| 14 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.19% | +0.23% | +624.76% | |
| 15 | FOXY | Simplify Currency Strtgy ETF | ETF-Other | 0.17% | — | +16.38% | |
| 16 | ABBV | Abbvie Inc | Stock-Healthcare | 0.16% | +0.07% | +100.63% | |
| 17 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.15% | +0.03% | — | |
| 18 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.15% | — | — | |
| 19 | PCT | Purecycle Technologies Inc | Stock-Other | 0.14% | +0.20% | +13.79% | |
| 20 | HODL | Vaneck Bitcoin ETF | ETF-Crypto | 0.14% | — | -5.48% | |
| 21 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.14% | +0.01% | -31.54% | |
| 22 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.13% | -0.13% | EXIT | |
| 23 | SBAR | Simplify Barrier Income ETF | ETF-Other | 0.13% | — | -75.16% | |
| 24 | AKRO | Akero Therapeutics Inc | Stock-Other | 0.13% | — | — | |
| 25 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.12% | +0.01% | +13.79% | |
| 26 | CVS | Cvs Health CORP | Stock-Healthcare | 0.12% | +0.04% | +80.82% | |
| 27 | TSLL | Dirx Dly Tsla Bul 2x Etf-aui | ETF-Other | 0.12% | — | — | |
| 28 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 0.11% | — | -22.33% | |
| 29 | EYE | National Vision Holdings Inc | Stock-Other | 0.11% | — | -29.65% | |
| 30 | MIST | Milestone Pharmaceuticals In | Stock-Other | 0.10% | +0.03% | +186.16% | |
| 31 | ABVX | Abivax Sa-adr | Stock-Other | 0.10% | — | — | |
| 32 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 0.09% | — | -21.23% | |
| 33 | NKTR | Nektar Therapeutics | Stock-Other | 0.09% | — | +67.65% | |
| 34 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.07% | — | -38.32% | |
| 35 | ACHV | Achieve Life Sciences Inc | Stock-Other | 0.07% | +0.08% | — | |
| 36 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.06% | -0.04% | -12.17% | |
| 37 | ✓ | Merus N V | Stock-Other | 0.06% | — | — | |
| 38 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.05% | — | +1.15% | |
| 39 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 0.05% | — | +13.85% | |
| 40 | INSM | Insmed Inc | Stock-Healthcare | 0.05% | -0.01% | +26.57% | |
| 41 | DCTH | Delcath Systems Inc | Stock-Other | 0.05% | +0.01% | +144.89% | |
| 42 | APLT | Applied Therapeutics Inc | Stock-Other | 0.05% | — | — | |
| 43 | LITL | Simplify Ppr Sndlr US Sm Cap | ETF-Other | 0.05% | — | — | |
| 44 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 0.04% | — | — | |
| 45 | ALHC | Alignment Healthcare Inc | Stock-Other | 0.04% | -0.05% | EXIT | |
| 46 | COR | Cencora Inc | Stock-Healthcare | 0.04% | — | -15.39% | |
| 47 | CLDX | Celldex Therapeutics Inc | Stock-Other | 0.04% | — | — | |
| 48 | TYA | Simplify Intermediate Term | ETF-Other | 0.04% | — | -94.76% | |
| 49 | MSOS | Advisorshares Pure US Cann | ETF-Other | 0.04% | — | — | |
| 50 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.04% | +0.01% | +13.76% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NXTI | Simplify Next Intg C Idx ETF | +0.5% | +3586.96% | Add |
| 2 | CVS | Cvs Health CORP | +0.1% | +80.82% | Add |
| 3 | TSLA | Tesla Inc | +0.1% | +0.91% | Add |
| 4 | MIST | Milestone Pharmaceuticals In | +0.1% | +186.16% | Add |
| 5 | REGN | Regeneron Pharmaceuticals | +0.1% | +251.12% | Add |
| 6 | ACHV | Achieve Life Sciences Inc | +0.1% | — | Add |
| 7 | HODL | Vaneck Bitcoin ETF | 0% | -5.48% | Add |
| 8 | GILD | Gilead Sciences Inc | 0% | +13.79% | Add |
| 9 | TSLL | Dirx Dly Tsla Bul 2x Etf-aui | 0% | — | Add |
| 10 | PCT | Purecycle Technologies Inc | 0% | +13.79% | Add |
| 11 | NBIX | Neurocrine Biosciences Inc | 0% | -21.23% | Add |
| 12 | ABBV | Abbvie Inc | — | +100.63% | Add |
| 13 | UNH | Unitedhealth Group Inc | -0.1% | +624.76% | Add |
| 14 | PM | Philip Morris International | -0.1% | -95.33% | Trim |
| 15 | TMO | Thermo Fisher Scientific Inc | -0.2% | +13.41% | Trim |
| 16 | ISRG | Intuitive Surgical Inc | -0.2% | -12.17% | Trim |
| 17 | CAH | Cardinal Health Inc | -0.2% | -47.38% | Trim |
| 18 | JNJ | Johnson & Johnson | -0.2% | +13.96% | Trim |
| 19 | CI | THE Cigna Group | -0.3% | +29.47% | Trim |
| 20 | ARQT | Arcutis Biotherapeutics Inc | -0.3% | -22.33% | Trim |
| 21 | DHR | Danaher CORP | -0.3% | -55.72% | Trim |
| 22 | LLY | Eli Lilly & Co | -0.3% | -31.54% | Trim |
| 23 | FOXY | Simplify Currency Strtgy ETF | -0.3% | +16.38% | Trim |
| 24 | PAGP | Plains Gp Holdings Lp-cl A | -0.6% | — | Unchanged |
| 25 | SPUC | Simplify US Eqty Plus Up | -1.8% | -14.57% | Trim |
| 26 | QIS | Simplify Multi-qis Alt ETF | -1.9% | +17.82% | Add |
| 27 | TYA | Simplify Intermediate Term | -1.9% | -94.76% | Trim |
| 28 | NMB | Simplify National Muni Bnd | -1.9% | -42.77% | Trim |
| 29 | AGGH | Simplify Aggregate Bond ETF | -2.7% | -28.40% | Trim |
| 30 | AGG | Ishares Core U.s. Aggregate | -6.1% | -9.86% | Trim |
| 31 | GLD | Spdr Gold Shares | -7% | +27.04% | Trim |
| 32 | IVV | Ishares Core S&p 500 ETF | -13.1% | -10.74% | Trim |
| 33 | SBIL | Simplify Govt Mny Mrkt ETF | — | NEW | New buy |
| 34 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | EXIT | Sold out |
| 35 | MSTR | Strategy Inc | — | EXIT | Sold out |
| 36 | IBIT | Ishares Bitcoin Trust ETF | — | NEW | New buy |
| 37 | CDX | Simplify High Yield ETF | — | EXIT | Sold out |
| 38 | XV | Simplify Target 15 Distr ETF | — | NEW | New buy |
| 39 | UTHR | United Therapeutics CORP | — | NEW | New buy |
| 40 | MLYS | Mineralys Therapeutics Inc | — | NEW | New buy |
| 41 | SBAR | Simplify Barrier Income ETF | — | NEW | New buy |
| 42 | ADMA | Adma Biologics Inc | — | EXIT | Sold out |
| 43 | EYE | National Vision Holdings Inc | — | NEW | New buy |
| 44 | MDGL | Madrigal Pharmaceuticals Inc | — | EXIT | Sold out |
| 45 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 46 | NKTR | Nektar Therapeutics | — | NEW | New buy |
| 47 | RNAGBP | Avidity Biosciences Inc | — | EXIT | Sold out |
| 48 | DGX | Quest Diagnostics Inc | — | EXIT | Sold out |
| 49 | ✓ | Merus N V | — | NEW | New buy |
| 50 | LITL | Simplify Ppr Sndlr US Sm Cap | — | NEW | New buy |
According to official SEC Form 13F filings, Simplify Asset Management Inc. reported a total U.S. public equity portfolio value of $7.2B across 128 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SBIL, IVV, GLD) accounted for 66.9% of total reported equity market value during Q3 2025.
Top New Position Initiated
SBIL
市值: $3.3B
Top Position Liquidated / Trimmed
SPY
前期市值: $487.8M
During Q3 2025, Simplify Asset Management Inc.'s top holdings by market value included SBIL (61.1%)、IVV (12.3%)、GLD (8.3%). The largest single position, SBIL, represented 61.1% of total portfolio value.
In Q3 2025, Simplify Asset Management Inc. made 49 total portfolio adjustments, initiating 11 new buys, adding to 14 positions, trimming 17 holdings, and fully liquidating 7 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.